A new hope with amazing results
Creating a new era in the brain stimulation and research, BrainsWay’s patented breakthrough treatment is based on Deep TMS (Transcranial Magnetic Stimulation), making it a non-invasive and effective treatment option.
Even though this is getting a popular treatment option, BrainsWay is continuously going through research and studies to expand the platform in making it the most trusted solution for treating major depression and OCD.
During a Brainsway Deep TMS session, the unique breakthrough technology – Deep TMS is used which reaches significant depth and breadth of the brain. This helps in producing broad stimulation and functional modulation in the targeted brain areas.
In the treatment, there is unique, patented coils fitted into a helmet, which is secured snugly on the patient’s head. Over 60 clinical trials worldwide have used BrainsWay’s therapy successfully. In the U.S., the device has been cleared by the FDA for treating major depressive disorder (MDD) since 2013. It has now received FDA clearance (De-Novo) for the treatment of Obsessive Compulsive Disorder (OCD).
| FOR PATIENTS | FOR HEALTH PROVIDERS |
| FDA-approved treatment | Clinically Proven |
| More effective than medications | Deeper and broader stimulation |
| Generally short 20-minute sessions | Financially feasible & attractive business model |
| Non-invasive, No systemic side effects | Effective alternative for treatment-resistant patients |
| Usually covered by major health insurances | Best-in-class customer support |
